Form D · Pharmaceuticals
ROCKWELL MEDICAL, INC.
Wixom, MI · CIK 0001041024
Offering snapshot reported Oct 30, 2018 · SEC filing
- Reported sold
- $22M Offering amount: $22M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 15, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 30, 2018 | Initial | $22,000,000 | No comparison | 1 | SEC filing |
| Oct 15, 2014 | Initial | $15,000,000 | No comparison | 1 | SEC filing |
| Dec 14, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jun 16, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-324597
Initial offering of $30,000,000, of which $22,000,000 was purchased as of October 15, 2018. Purchaser had a right to purchase an additional $8,000,000 through October 26, 2018, which right expired unexercised. No additional amount remains to be sold.
Source: Form D, filed Oct 30, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Patrick J. Bagley | Director |
| Ronald D. Boyd | Director |
| Robert L. Choini | Director, Executive |
| Lisa N. Colleran | Director |
| John G. Cooper | Director |
| Ajay Gupta | Executive |
| Kenneth L. Holt | Director |
| Thomas E. Klema | Executive |
| Stuart Paul | Director, Executive |
| Raymond D. Pratt | Executive |
| Mark H. Ravich | Director |
| Robin Smith | Director |
| Benjamin Wolin | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
30142 Wixom Road
Wixom, MI, 48393
Wixom, MI, 48393